LongCovidPharmD on Substack
summary of a Harvard preprint of a long covid patient survey addressing patient responses to a variety of possible Long Covid treatments
(So of course we will probably never get access to this.)
“The goal of this study is to confirm that niclosamide can solve the complex symptoms of Long COVID through multiple mechanisms such as virus suppression, inflammation suppression, and neuroprotection. We hope that the clinical trial will be successful and provide a practical treatment option for Long COVID patients, which will be historic."